nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylhexedrine—TAAR1—female reproductive system—ovarian cancer	0.297	0.297	CbGeAlD
Propylhexedrine—SLC18A2—uterine cervix—ovarian cancer	0.135	0.135	CbGeAlD
Propylhexedrine—SLC18A2—endometrium—ovarian cancer	0.122	0.122	CbGeAlD
Propylhexedrine—SLC18A2—uterus—ovarian cancer	0.112	0.112	CbGeAlD
Propylhexedrine—SLC18A2—female reproductive system—ovarian cancer	0.101	0.101	CbGeAlD
Propylhexedrine—SLC18A2—vagina—ovarian cancer	0.0914	0.0914	CbGeAlD
Propylhexedrine—SLC18A2—testis—ovarian cancer	0.0816	0.0816	CbGeAlD
Propylhexedrine—SLC18A2—lymph node—ovarian cancer	0.0591	0.0591	CbGeAlD
